tiprankstipranks
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF

Neuren Pharmaceuticals Limited (NURPF) Ownership - Who Owns Neuren Pharmaceuticals Limited?

25 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 14, 2023
Joseph Basile
Non Executive,director
BoughtAU$59950
Jun 14, 2023
Trevor Donald Scott
Non Executive,director
SoldAU$15275000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
21,290,323Insider16.38%266,767,747
17,928,907Insider13.80%224,649,205
2,414,784Insider1.86%30,257,244
2,084,680Insider1.60%26,121,040
1,807,167Institution1.39%22,643,803
1,416,721Institution1.09%17,751,514
398,207Insider0.31%4,989,534
264,634Insider0.20%3,315,864
209,505Institution0.16%2,625,098
105,000Insider0.08%1,315,650

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Neuren Pharmaceuticals Limited (NURPF)?
Currently, no data Available
What percentage of Neuren Pharmaceuticals Limited (NURPF) stock is held by institutional investors?
Currently, no data Available
What percentage of Neuren Pharmaceuticals Limited (NURPF) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Neuren Pharmaceuticals Limited (NURPF)?
Larry Glass owns the most shares of Neuren Pharmaceuticals Limited (NURPF).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis